About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Philadelphia | 631 Studies

Clinical Trials Breast CancerPhiladelphia

Breast Cancer Clinical Trials in Philadelphia

Find 631 clinical trials for breast cancer near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 421-440 of 631 trials

CompletedAcupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint PainRATIONALE: Acupuncture may help relieve moderate or severe joint pain caused by aromatase inhibitors.NCT01013337·Philadelphia, Pennsylvania Active not recruitingRoll Over StudY for Patients Who Have Completed a Previous Oncology Study With OlaparibThe rationale of the ROSY-O study is to continue to provide study treatment for patients who have participated in a parent study with olaparib and who are continuing to derive…NCT04421963·Boca Raton, Florida and 106 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

RecruitingPartial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)Breast-conserving surgery followed by re-irradiation with partial breast irradiation (rPBI) has recently been found to be a safe alternative to mastectomy for women who have…NCT05592938·New York, New York and 18 others

CompletedhTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of RelapseThis is a Phase I, open label study to evaluate the safety, tolerability, and immunogenicity of INO-1400 or INO-1401 alone or in combination with INO-9012, delivered by…NCT02960594·Detroit, Michigan and 5 others

Active not recruitingStudy of JANX008 in Subjects With Advanced or Metastatic Solid Tumor MalignanciesThis study is a first-in-human (FIH), Phase 1/1b, open-label, multicenter dose escalation and dose expansion study to assess the safety, tolerability, pharmacokinetics (PK)…NCT05783622·Duarte, California and 17 others

TerminatedStudy of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast CancerThe purpose of this study is to determine the safety profile, maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D) of single agent ISB1302 in subjects with…NCT03983395·Gilbert, Arizona and 4 others

CompletedA Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsPhase 1/2 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of SNS-101, a novel anti VISTA IgG1 monoclonal antibody as monotherapy or in…NCT05864144·Los Angeles, California and 9 others

CompletedAssessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.This open label, randomised, controlled, multi-centre phase III study will assess the efficacy and safety of single agent olaparib vs standard of care based on physician's choice…NCT02000622·San Diego, California and 170 others

Active not recruitingStudy BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 ExpressionThis clinical trial is evaluating a drug called BT5528 alone and in combination with nivolumab in participants with advanced solid tumors historically known for expression of…NCT04180371·Encinitas, California and 27 others

CompletedAddressing Sexual Concerns in Breast Cancer: Patient Intervention StudyThe goal of this study is to evaluate an educational video intervention (called Starting the Conversation) aimed to enhance breast cancer patients' beliefs about and communication…NCT03624972·Philadelphia, Pennsylvania

CompletedSubharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant ChemotherapyThis is a diagnostic accuracy study to evaluate if two novel ultrasound (US) techniques, quantitative 3D subharmonic imaging (SHI) and Subharmonic Aided Pressure Estimation…NCT02115607·Philadelphia, Pennsylvania

RecruitingDe-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor…NCT04852887·Birmingham, Alabama and 831 others

Active not recruitingA Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsThe purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.NCT05787587·Phoenix, Arizona and 26 others

Active not recruitingHormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)This randomized phase III trial studies the best individual therapy for women who have node-negative, estrogen-receptor positive breast cancer by using a special test (Oncotype…NCT00310180·Anniston, Alabama and 1221 others

Active not recruitingThe Breast Program - Translational Cancer ResourceTRACR will provide a data/biospecimen repository for translational research to better diagnose, prognose, treat and cure breast cancer (and related diseases/treatment conditions).NCT02798341·Philadelphia, Pennsylvania

Active not recruitingNiraparib in Combination With Trastuzumab in Metastatic HER2+ Breast CancerThe human epidermal growth factor receptor 2 (HER2) regulates cell growth and survival.NCT03368729·Birmingham, Alabama and 6 others

Active not recruitingImaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CTPatients with known or suspected, in the opinion of an investigator, primary or metastatic breast cancer may be eligible for this study.NCT03846167·Philadelphia, Pennsylvania

Active not recruitingA Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)This is an open-label, first-in-human study designed to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity of selpercatinib (also known…NCT03157128·Scottsdale, Arizona and 84 others

CompletedA Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast CancerThis is a multicenter, open label, Phase 1b study in patients with mBC.NCT02684032·Birmingham, Alabama and 40 others

TerminatedThe CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerThe purpose of this study is to determine whether maximal estrogen suppression achieved via the combination of an experimental drug, atamestane, plus an FDA-approved drug…NCT00097344·Mobile, Alabama and 103 others

PreviousPage 22 of 32Next

Other Conditions in Philadelphia

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma